User profiles for Zain Chagla
 | Zain ChaglaMcMaster University Verified email at mcmaster.ca Cited by 1085 |
The BNT162b2 (BioNTech/Pfizer) vaccine had 95% efficacy against COVID-19≥ 7 days after the 2nd dose
Z Chagla - Annals of internal medicine, 2021 - acpjournals.org
The BNT162b2 (BioNTech/Pfizer) vaccine had 95% efficacy against COVID-19 ≥7 days after
the 2nd dose | Annals of Internal Medicine Advertisement ACP Online Annals of Internal …
the 2nd dose | Annals of Internal Medicine Advertisement ACP Online Annals of Internal …
The efficacy and safety of hydroxychloroquine for COVID-19 prophylaxis: A systematic review and meta-analysis of randomized trials
…, L Carayannopoulos, K Dearness, Z Chagla… - PloS one, 2021 - journals.plos.org
Background Populations such as healthcare workers (HCW) that are unable to practice physical
distancing are at high risk of acquiring Coronavirus disease-2019 (COVID-19). In these …
distancing are at high risk of acquiring Coronavirus disease-2019 (COVID-19). In these …
Re: it is time to address airborne transmission of COVID-19
To the Editor—We are concerned that the commentary by Morowska and Milton [1] has
caused significant confusion. We agree that there is a gradient from large droplets to aerosols. …
caused significant confusion. We agree that there is a gradient from large droplets to aerosols. …
The risk of allergic reaction to SARS-CoV-2 vaccines and recommended evaluation and management: a systematic review, meta-analysis, GRADE assessment, and …
Concerns for anaphylaxis may hamper severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
immunization efforts. We convened a multidisciplinary group of international …
immunization efforts. We convened a multidisciplinary group of international …
COVID-19 boosters in rich nations will delay vaccines for all
To the Editor—On 4 August 2021, Tedros Adhanom Ghebreyesus, Director-General of the
World Health Organization, called for a global moratorium on booster doses of vaccination …
World Health Organization, called for a global moratorium on booster doses of vaccination …
Prescribing nirmatrelvir/ritonavir for COVID-19 in advanced CKD
As of December 2021, 18.2 million have died globally from coronavirus disease 2019 (COVID-19)
due to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and …
due to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and …
Novel coronavirus COVID-19: current evidence and evolving strategies
…, S Ekhtiari, Y Chang, SA Phillips, M Zhu, Z Chagla… - JBJS, 2020 - journals.lww.com
“If anything kills over 10 million people in the next few decades, it’s most likely to be a highly
infectious virus, rather than a war. Not missiles, but microbes. Now, part of this reason is that …
infectious virus, rather than a war. Not missiles, but microbes. Now, part of this reason is that …
In adults, the Oxford/AstraZeneca vaccine had 70% efficacy against COVID-19> 14 d after the 2nd dose
Z Chagla - Annals of Internal Medicine, 2021 - acpjournals.org
In adults, the Oxford/AstraZeneca vaccine had 70% efficacy against COVID-19 >14 d after the
2nd dose | Annals of Internal Medicine Advertisement ACP Online Annals of Internal Medicine …
2nd dose | Annals of Internal Medicine Advertisement ACP Online Annals of Internal Medicine …
Medical masks versus N95 respirators for preventing COVID-19 among health care workers: a randomized trial
Background: It is uncertain if medical masks offer similar protection against COVID-19 compared
with N95 respirators. Objective: To determine whether medical masks are noninferior to …
with N95 respirators. Objective: To determine whether medical masks are noninferior to …
Safety of hydroxychloroquine among outpatient clinical trial participants for COVID-19
Background Use of hydroxychloroquine in hospitalized patients with coronavirus disease
2019 (COVID-19), especially in combination with azithromycin, has raised safety concerns. …
2019 (COVID-19), especially in combination with azithromycin, has raised safety concerns. …
